Today, 27th November 2020 Icon Group’s second cancer centre in Mainland China was officially opened. The new Icon Cancer Centre in Chongqing, a megacity in southwest China will offer the latest in radiation therapy technology and techniques benefitting the millions of people living in Chongqing and surrounding regions.
Alongside experienced doctors and clinical teams, the centre, located inside Sanbo Chang’an Hospital (Sanbo), is equipped with a Varian TrueBeam linear accelerator which has the capability to deliver the most advanced cutting-edge treatment techniques for a wide range of cancers. It will also be the first in China to offer Varian’s HyperArc technology, an advanced treatment technique delivering pin-point radiation to multiple brain tumours rather than treating the whole brain with radiation.
Icon Group CEO, Mark Middleton said this centre is a milestone in the group’s rich history and commitment to pushing the boundaries of cancer care.
“Last year we became the first Australian healthcare company to bring cancer care into China, turning the tide of radiation oncology for the Jiangxian community in China’s Shanxi province. Today, we build on that commitment and utilise our long-standing expertise and innovation to bring another world-class level of care to the deserving people of Chongqing,” said Mr Middleton.
The centre’s state-of-the-art service is underpinned by Icon Group’s specialised remote functions based in Australia. This includes one of Australia’s most cutting-edge exports – radiation therapy planning. This service model sees a centralised team of dosimetry specialists work across all time zones to provide efficient turnarounds and the development of high quality, high complexity treatment plans.